Abstract: Algorithms for finding minimum or bounded vertex covers in graphs use a branch-and-reduce strategy, which involves exploring a highly imbalanced search tree. Prior GPU solutions assign ...
Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...
The Enhanced Reconsideration System (ERS) is a production-grade AI memory management library designed to transform stateless AI agents into stateful ones. It integrates asynchronous promise chains, ...
An EVA Air Boeing 787-9 aircraft suffered a tail strike while performing a go-around at Taiwan Taoyuan International Airport (TPE) in Taiwan. The incident involved the airline’s Boeing 787-9 ...
Hosted on MSN
Where Will Recursion Pharmaceuticals Be in 5 Years?
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...
A photo of what appeared to be a dinosaur tail trapped in amber captured the attention of millions in September 2025 when it was shared on social media. An X post (archived) viewed over 12 million ...
Shares of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results